The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|June 2, 2019
- Pharmaceutical Technology-06-02-2019
- Volume 43
- Issue 6
Pharmaceutical Technology North America, June 2019 (PDF)
Click the title above to open the Pharmaceutical Technology June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Hovione Technology Develops Blister-Based Inhalerover 7 years ago
Enabling Technologies Advance Poorly Soluble Highly Potent APIsover 7 years ago
Pharma Facilities Still Have a Lot to Learnover 7 years ago
Filling the Early Intermediate Security Gapover 7 years ago
As Easy as ABC?over 7 years ago
Regulating Cannabis-Based Medicines in Europeover 7 years ago
Supply Chain Risk and Security Maturity Evolutionover 7 years ago
On the Right Trackover 7 years ago
Looking Beyond the Solubility Horizonover 7 years ago
Enhancing Bioavailability with Hot-Melt ExtrusionAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
1074 Revision Needs Formulator Feedback: AAPS PharmSci 360 2026
5